Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqCM - Nasdaq Real Time Price USD

Intelligent Bio Solutions Inc. (INBS)

1.2000
+0.0600
+(5.33%)
As of 12:19:37 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Total Revenue
3,031.4050
3,111.7810
1,256.8720
0
0
Cost of Revenue
1,467.4440
1,686.1550
930.2040
0
--
Gross Profit
1,563.9610
1,425.6260
326.6680
0
--
Operating Expense
12,319.1560
11,708.8000
8,763.2310
8,336.8760
5,573.4820
Operating Income
-10,755.1950
-10,283.1740
-8,436.5630
-8,336.8760
-5,573.4820
Net Non Operating Interest Income Expense
22.8980
-82.3180
-213.8580
6.8870
-1,079.8020
Other Income Expense
-1.4240
174.5600
-2,014.1340
-3.9870
-406.9170
Pretax Income
-10,733.7210
-10,190.9320
-10,664.5550
-8,333.9760
-7,060.2010
Tax Provision
--
--
--
--
0
Net Income Common Stockholders
-10,697.0170
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Diluted NI Available to Com Stockholders
-10,697.0170
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Basic EPS
0.12
-6.38
-127.00
-136.80
-149.93
Diluted EPS
0.12
-6.38
-127.00
-136.80
-149.93
Basic Average Shares
3,393.5070
1,592.7460
83.7170
61.1050
56.5920
Diluted Average Shares
3,393.5070
1,592.7460
83.7170
61.1050
56.5920
Total Operating Income as Reported
-10,755.1950
-10,283.1740
-12,595.2330
-8,336.8760
-5,573.4820
Rent Expense Supplemental
39.6090
--
--
--
--
Total Expenses
13,786.6000
13,394.9550
9,693.4350
8,336.8760
5,573.4820
Net Income from Continuing & Discontinued Operation
-10,697.0170
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Normalized Income
-10,695.5930
-10,331.3190
-8,617.5860
-8,302.0640
-6,766.0610
Interest Income
155.9510
84.8220
9.6760
14.4260
13.8060
Interest Expense
133.0530
167.1400
223.5340
7.5390
1,093.6080
Net Interest Income
22.8980
-82.3180
-213.8580
6.8870
-1,079.8020
EBIT
-10,600.6680
-10,023.7920
-10,441.0210
-8,326.4370
-5,966.5930
EBITDA
-9,374.7100
-8,810.7070
-9,474.2890
-8,326.4370
-5,966.5930
Reconciled Cost of Revenue
1,450.4860
1,674.3440
930.2040
0
--
Reconciled Depreciation
1,225.9580
1,213.0850
966.7320
0
--
Net Income from Continuing Operation Net Minority Interest
-10,697.0170
-10,156.7590
-10,631.7200
-8,306.0510
-7,037.2860
Total Unusual Items Excluding Goodwill
-1.4240
174.5600
-2,014.1340
-3.9870
-271.2250
Total Unusual Items
-1.4240
174.5600
-2,014.1340
-3.9870
-271.2250
Normalized EBITDA
-9,373.2860
-8,985.2670
-7,460.1550
-8,322.4500
-5,695.3680
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
6/30/2021 - 12/23/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HSCS HeartSciences Inc.
3.4900
+0.87%
 
BBLG Bone Biologics Corporation
0.6900
+2.80%
 
TNON Tenon Medical, Inc.
1.0850
-0.46%
 
TIVC Tivic Health Systems, Inc.
4.1863
-2.64%
 
AIMD Ainos, Inc.
0.5251
-2.58%
 
CODX Co-Diagnostics, Inc.
0.3683
+5.23%
 
AMIX Autonomix Medical, Inc.
1.7200
-4.97%
 
BJDX Bluejay Diagnostics, Inc.
1.7666
+2.13%
 
MDAI Spectral AI, Inc.
1.1596
-0.03%
 
VTAK Catheter Precision, Inc.
0.2834
+1.29%